podophyllotoxin has been researched along with Chronic Illness in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, B; Du, J; Fu, MH; Pan, YY; Tao, XF | 1 |
| Fan, B; Ge, J; Ge, L; Lu, H; Ma, J; Qian, J; Zhong, X | 1 |
| Fleischl, G; Götz, M; Jarisch, R; Wantke, F | 1 |
| Gétaz, EP; Staples, WG | 1 |
| Illiger, HJ; Labedzki, L | 1 |
| Batz, K; Brunner, KW; Cavalli, F; Ryssel, HJ; Sonntag, RW | 1 |
| Chlud, K | 1 |
| Deicher, H; Fricke, R; Krull, P | 1 |
| Novotný, F | 1 |
| Szántó, L | 1 |
1 trial(s) available for podophyllotoxin and Chronic Illness
| Article | Year |
|---|---|
[The P phenomenon in progressive chronic polyarthritis (pcP) and collagen diseases].
Topics: Adult; Animals; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; C-Reactive Protein; Chronic Disease; Collagen Diseases; Cyclophosphamide; Ethanolamines; Female; Humans; Injections, Intramuscular; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Rheumatoid Factor; Triaziquone; Vasoconstrictor Agents | 1969 |
9 other study(ies) available for podophyllotoxin and Chronic Illness
| Article | Year |
|---|---|
Safety and efficacy of a low frame rate protocol for percutaneous coronary intervention for chronic total occlusions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Thioguanine; Treatment Outcome | 2021 |
Safety and feasibility of a low frame rate protocol for percutaneous coronary intervention to chronic total occlusions: preliminary experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Feasibility Studies; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Registries; Thioguanine; Treatment Outcome | 2018 |
Topical podophyllotoxin in psoriasis vulgaris.
Topics: Administration, Cutaneous; Adult; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Podophyllotoxin; Psoriasis; Recurrence | 1993 |
Chronic myelomonocytic leukaemia: a case report.
Topics: Aged; Chronic Disease; Etoposide; Humans; Leukemia, Myeloid; Male; Podophyllotoxin | 1977 |
[Successful therapy of chronic myelomonocytic leukemia with vp 16-213 (author's transl)].
Topics: Age Factors; Aged; Chronic Disease; Etoposide; Granulocytes; Humans; Leukemia; Male; Monocytes; Podophyllotoxin | 1979 |
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Chemical Phenomena; Chemistry; Chronic Disease; Drug Evaluation; Female; Glucosides; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous | 1975 |
[Treatment of chronic connective tissue diseases with cytostatics].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Chronic Disease; Collagen Diseases; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisolone; Spondylitis, Ankylosing; Thiotepa; Triaziquone | 1970 |
[Combined antipsoriatic sticks with cytostatics].
Topics: Antineoplastic Agents; Chronic Disease; Humans; Pharmaceutic Aids; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Psoriasis | 1971 |
[Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
Topics: Arthritis, Rheumatoid; Chronic Disease; Humans; Immunosuppressive Agents; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum | 1969 |